Skip to content
ClinCalc Pro
Menu
ACE inhibitor + thiazide diuretic

Quinapril with hydrochlorothiazide

Brand names: Accuretic

This is a fixed-dose oral combination of quinapril, an ACE inhibitor, with hydrochlorothiazide, a thiazide diuretic, used for essential hypertension not adequately controlled on quinapril alone.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Quinapril inhibits angiotensin-converting enzyme to lower angiotensin-II-mediated vasoconstriction and aldosterone secretion, while hydrochlorothiazide increases renal sodium and water excretion; the ACE inhibitor offsets diuretic-induced renin-angiotensin activation.

Prescribing in practice

  • Avoid in pregnancy because the ACE-inhibitor component is foetotoxic; counsel women of childbearing potential and review contraception.
  • ACE inhibitors can cause angioedema requiring permanent withdrawal and a persistent dry cough, while the thiazide adds risks of hyponatraemia, hypokalaemia, hyperuricaemia and glucose intolerance.
  • First-dose hypotension, hyperkalaemia and renal impairment can occur, especially with volume depletion, renal artery stenosis or NSAIDs.

Monitoring

Monitor blood pressure, renal function and serum electrolytes including sodium and potassium at baseline and after dose changes.

Counselling the patient

  • Seek urgent help for swelling of the face, lips, tongue or throat.
  • Report a persistent dry cough so an alternative can be considered.
  • Tell your doctor immediately if you become pregnant.

Evidence & guidelines

Combining an ACE inhibitor with a thiazide diuretic is an established step in NICE hypertension management, and the fixed-dose combination supports adherence.

Reference: NICE NG136; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.